BMCRX
Price
$23.55
Change
+$0.16 (+0.68%)
Updated
May 8 closing price
Net Assets
1.32B
RGACX
Price
$70.16
Change
+$0.52 (+0.75%)
Updated
May 8 closing price
Net Assets
283.8B
Ad is loading...

BMCRX vs RGACX

Header iconBMCRX vs RGACX Comparison
Open Charts BMCRX vs RGACXBanner chart's image
BlackRock Advantage Large Cap Gr R
Price$23.55
Change+$0.16 (+0.68%)
VolumeN/A
Net Assets1.32B
American Funds Growth Fund of Amer R3
Price$70.16
Change+$0.52 (+0.75%)
VolumeN/A
Net Assets283.8B
BMCRX vs RGACX Comparison Chart
Loading...
View a ticker or compare two or three
VS
BMCRX vs. RGACX commentary
May 09, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BMCRX is a Buy and RGACX is a StrongBuy.

Ad is loading...
FUNDAMENTALS
Fundamentals
RGACX has more cash in the bank: 284B vs. BMCRX (1.32B). RGACX pays higher dividends than BMCRX: RGACX (0.08) vs BMCRX (0.00). BMCRX was incepted earlier than RGACX: BMCRX (15 years) vs RGACX (23 years). BMCRX (1.40) is less costly to investors than RGACX (0.94). BMCRX is a more actively managed with annual turnover of: 128.00 vs. RGACX (25.00). BMCRX has a lower initial minimum investment than RGACX: BMCRX (100) vs RGACX (250). RGACX annual gain was more profitable for investors over the last year : 3.09 vs. BMCRX (-7.88). RGACX return over 5 years is better than : 42.06 vs. BMCRX (34.55).
BMCRXRGACXBMCRX / RGACX
Total Expense Ratio1.120.94119%
Annual Report Gross Expense Ratio1.400.94149%
Fund Existence15 years23 years-
Gain YTD-6.177-2.542243%
Front LoadN/AN/A-
Min. Initial Investment10025040%
Min. Initial Investment IRAN/AN/A-
Net Assets1.32B284B0%
Annual Yield % from dividends0.000.08-
Returns for 1 year-7.883.09-255%
Returns for 3 years30.2132.7992%
Returns for 5 years34.5542.0682%
Returns for 10 years80.8558.28139%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
EBS6.361.62
+34.18%
Emergent Biosolutions
VINP9.960.19
+1.94%
Vinci Partners Investments Ltd
SLVM60.200.97
+1.64%
Sylvamo Corp
IBKR179.79N/A
N/A
Interactive Brokers Group
UCAR2.90-0.03
-1.02%
U Power Limited